Success Metrics

Clinical Success Rate

66.7%

Based on 2 completed trials

Completion Rate

67%(2/3)

Active Trials

0(0%)

Results Posted

50%(1 trials)

Terminated

1(25%)

Phase Distribution

Ph phase_1

75%

Ph not_applicable

25%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

Phase 1Safety & dosage

3(75.0%)

N/ANon-phased studies

1(25.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

50.0%

2 of 4 finished

Non-Completion Rate

50.0%

2 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(2)

Terminated(2)

Detailed Status

Completed2

Withdrawn1

Terminated1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

66.7%

Most Advanced

Phase 1

Trials by Phase

Phase 13 (75.0%)

N/A1 (25.0%)

Trials by Status

withdrawn125%

completed250%

terminated125%

Recent Activity

0 active trials

Showing 4 of 4

completedphase_1

Vitamin D in OUD: Exploration of Alterations on the Dopamine D2/D3 Receptor System

NCT06261905

terminatednot_applicable

Understanding Dopamine Mechanisms in Cocaine Addiction Using AMPT and Methylphenidate With [11C]RAC/[11C]PHNO PET

NCT02152670

withdrawnphase_1

Concurrent PET D2/D3 Receptor Imaging and fMRI Smoking Cue Reactivity in Smokers

NCT01784016

completedphase_1

A PET Study in Healthy Volunteers

NCT01424449

Clinical Trials (4)

Showing 4 of 4 trials

NCT06261905Phase 1

Vitamin D in OUD: Exploration of Alterations on the Dopamine D2/D3 Receptor System

Completed

NCT02152670Not Applicable

Understanding Dopamine Mechanisms in Cocaine Addiction Using AMPT and Methylphenidate With [11C]RAC/[11C]PHNO PET

Terminated

NCT01784016Phase 1

Concurrent PET D2/D3 Receptor Imaging and fMRI Smoking Cue Reactivity in Smokers

Withdrawn

NCT01424449Phase 1

A PET Study in Healthy Volunteers

Completed

All 4 trials loaded

Drug Details

Intervention Type: RADIATION
Total Trials: 4